Amoxapine sodium 90 mg subq q 12 hours.
Docusate sodium 100 mg po b.i.d.
Albuterol one to two puffs IH q 4 p.r.n.
Captopril 25 mg po t.i.d.
Clonazepam 1 mg po t.i.d., 6.
Lansoprazole 30 mg nasogastric q.d.
Lorazepam .5 mg intravenous q 6 p.r.n.
Acetaminophen 325 to 650 mg po q 4 to 6 p.r.n.
Lactulose 30 ml po q 8 p.r.n.
Milk of Magnesia 30 ml po q 6 h p.r.n.
Zolpidem tartrate 5 mg po q.h.s.
Ipratropium bromide two puffs IH q 4 to 6 hours p.r.n.
Atenolol 75 mg po q day.
Warfarin 5 mg po q day; will need INR checks.
Hematology:  The patient's Coumadin was held beginning on [**12-26**] for possible PICC line placement, however, given lack of necessity for intravenous antibiotics PICC line placement was deferred.
Coumadin will be initiated on [**12-27**] (Coumadin of 10 mg).
Please initiate Warfarin 5 mg po q.h.s.
We increased beta blocker Atenolol 75 mg po q day.
Infectious disease:  Patient received a nine day course of Tobramycin, Linezolid and Imipenem for Pseudomonas aureus sputum/tracheal bronchitis.
We recommend monitoring the patient off of antibiotics.
Prophylaxis:  On Pepcid, Lovenox, Coumadin re-initiated on [**12-27**].
Thoracentesis for liver.
Cholecystostomy tube.
Checking metabolic panel over three to five days to ensure adequate electrolyte repletion when given tube feeding.
